There is anatomical and functional evidence that ventral midbrain dopaminergic (DA) cell groups and the subthalamic nucleus (STN) receive noradrenergic innervation in rodents, but much less is known about these interactions in primates. Degeneration of NE neurons in the locus coeruleus (LC) and related brainstem NE cell groups is a well-established pathological feature of Parkinson's disease (PD), but the development of such pathology in animal models of PD has been inconsistent across species and laboratories. We recently demonstrated 30-40% neuronal loss in the LC, A5 and A6 NE cell groups of rhesus monkeys rendered parkinsonian by chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this study, we used dopamine-beta-hydroxylase (DβH) immunocytochemistry to assess the impact of this neuronal loss on the number of NE terminal-like varicosities in the substantia nigra pars compacta (SNC), ventral tegmental area (VTA), retrorubral field (RRF) and STN of MPTP-treated parkinsonian monkeys. Our findings reveal that the NE innervation of the ventral midbrain and STN of normal monkeys is heterogeneously distributed being far more extensive in the VTA, RRF and dorsal tier of the SNC than in the ventral SNC and STN. In parkinsonian monkeys, all regions underwent a significant (~50-70%) decrease in NE innervation. At the electron microscopic level, some DβH-positive terminals formed asymmetric axo-dendritic synapses in VTA and STN. These findings demonstrate that the VTA, RRF and SNCd are the main ventral midbrain targets of ascending NE inputs, and that these connections undergo a major break-down in chronically MPTP-treated parkinsonian monkeys. This severe degeneration of the ascending NE system may contribute to the pathophysiology of ventral midbrain and STN neurons in PD.
Introduction
Norepinephrine is an abundant and widely distributed neurotransmitter in the central nervous system (CNS). The LC contains more than half of brain NE neurons (Gaspar, 1994; Aston-Jones et al., 2000; Aston-Jones, 2004 ) and sends projections throughout the CNS (Lindvall et al., 1974; Swanson and Hartman, 1975; Jones et al., 1977; Jones and Moore, 1977; Carpenter et al., 1981; Foote et al., 1983; Nieuwenhuys et al., 1988; Geisler and Zahm, 2005) . Although there is significant evidence for NE-mediated effects on various populations of midbrain dopamine (DA) neurons (Grenhoff and Svensson, 1988; Grenhoff et al., 1995) , the ventral tegmental area (VTA) and the retrorubral field (RRF) receive a stronger NE innervation than the substantia nigra pars compacta (SNC) in rodents (Jones et al., 1977; Phillipson, 1979; Simon et al., 1979; Mejias-Aponte et al., 2009) . Another basal ganglia target of NE afferents in rodents is the STN (Arcos et al., 2003; Belujon et al., 2007) . Despite some advances in knowledge of the anatomy and physiology of NE in the rodent ventral midbrain and STN, much remains to be known about these interactions in primates (Ginsberg et al., 1993; Liprando et al., 2004; Vogt et al., 2008) .
Degeneration of the LC and other brainstem NE cell groups is one of the pathological hallmarks of idiopathic PD and other neurodegenerative disorders (Chan-Palay and Asan, 1989; Chan-Palay, 1991) . In fact, there is evidence that NE cell loss may occur prior to midbrain DA neurons degeneration in PD (Braak et al., 2003; Zarow et al., 2003; Halliday et al., 2006; Sotiriou et al., 2010) . Animal models of PD have been inconsistent in mimicking NE cell loss (Forno et al., 1986; Gibb et al., 1989; Herrero et al., 1993) , most likely due to differences in the type of toxins used, their regimen of administration, and the rigor with which quantitative methods were applied to assess these changes (Burns et al., 1983; Langston et al., 1984; Mitchell et al., 1985; Snyder and D'Amato, 1986;  Neurobiology of Disease 100 (2017) 9-18
